Novartis’s Canakinumab Fails In COVID-19 Pneumonia Patients

Dexamethasone Remains Only Proven Therapy In Severe Disease

 
• By Andrew McConaghie
  
Basel, Switzerland - 27 August, 2016: sign on the wall of a Novartis building. Novartis International AG is a Swiss pharmaceutical company based in Basel, Switzerland.
The trial aimed to help hospitalized patients not yet on mechanical ventilation but failed to show an impact on mortality rates. • Source: Archive
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip